Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

BIO Statement on Reintroduction of the PASTEUR Act

February 5, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act:"The introduction of the PASTEUR Act of…

BIO Statement on Passage of Bipartisan Appropriations Package

February 3, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and families living with rare diseases. We thank the bill’s…

BIO Appoints Joe Franklin, JD, PhD, as Chief Legal and Policy Officer

February 2, 2026

Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and digital health. As a member of BIO’s senior…